Page last updated: 2024-08-22

angiotensin ii and bay 58-2667

angiotensin ii has been researched along with bay 58-2667 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Artmeier-Brandt, U; Frey, R; Mück, W; Unger, S; Weimann, G; Wensing, G	1
Durgin, BG; Freitag, D; Hafeez, N; Hahn, SA; Mathar, I; Miller, MP; Sandner, P; Schmidt, HM; Straub, AC	1

Trials

1 trial(s) available for angiotensin ii and bay 58-2667

Article	Year
Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers. Journal of clinical pharmacology, 2008, Volume: 48, Issue:12 Topics: Adult; Angiotensin II; Area Under Curve; Benzoates; Blood Pressure; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activators; Guanylate Cyclase; Half-Life; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Molecular Structure; Norepinephrine; Receptors, Cytoplasmic and Nuclear; Renin; Soluble Guanylyl Cyclase; Treatment Outcome; Young Adult	2008

Article

Year

Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers.

Journal of clinical pharmacology, 2008, Volume: 48, Issue:12

Topics: Adult; Angiotensin II; Area Under Curve; Benzoates; Blood Pressure; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activators; Guanylate Cyclase; Half-Life; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Molecular Structure; Norepinephrine; Receptors, Cytoplasmic and Nuclear; Renin; Soluble Guanylyl Cyclase; Treatment Outcome; Young Adult

2008

Other Studies

1 other study(ies) available for angiotensin ii and bay 58-2667

Article	Year
Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation. JCI insight, 2019, 10-03, Volume: 4, Issue:19 Topics: Angiotensin II; Animals; Benzoates; Blood Pressure; Cytochrome-B(5) Reductase; Genotype; Heme; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Nitric Oxide; Oxidation-Reduction; Soluble Guanylyl Cyclase; Transcriptome; Vasodilation	2019

Article

Year

Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation.

JCI insight, 2019, 10-03, Volume: 4, Issue:19

Topics: Angiotensin II; Animals; Benzoates; Blood Pressure; Cytochrome-B(5) Reductase; Genotype; Heme; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Nitric Oxide; Oxidation-Reduction; Soluble Guanylyl Cyclase; Transcriptome; Vasodilation

2019